JNJ vs SNTI · P/E 17, rev $49.37B vs rev $33.0K
Johnson & Johnson (JNJ) versus Senti Biosciences Inc (SNTI) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Senti Biosciences Inc (SNTI) is a biotechnology company listed on NASDAQ.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported SNTI revenue for 2026-06-30 was $33.0K. Net income was -$17.0M. SNTI currently screens at market cap $29.6M.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. SNTI currently screens at market cap $29.6M.
Not investment advice. Open the JNJ and SNTI stock pages for the full models.
Not investment advice.